InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Galdes Alphonse, Vice-Président Exécutif. Director active across 1 company, notably BIOGEN INC.. In total, 1 disclosures have been published. History available since 19 January 2022. The latest transaction was disclosed on 19 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Galdes Alphonse
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
658 shares0Common StockSEC:0001127602-22-001864:0
1 of 1 declaration
About Galdes Alphonse
Alphonse Galdes is the Executive Vice President of Pharmaceutical Operations & Technology at BIOGEN INC. He is responsible for overseeing technical operations and pharmaceutical production, thereby contributing to the innovation and efficiency of the company's processes. His role is essential in ensuring that BIOGEN maintains its high standards of quality and compliance in the pharmaceutical sector.
